BRPI1013539A2 - composição farmacêutica sublingual compreendendo um óleo neutro - Google Patents

composição farmacêutica sublingual compreendendo um óleo neutro

Info

Publication number
BRPI1013539A2
BRPI1013539A2 BRPI1013539A BRPI1013539A BRPI1013539A2 BR PI1013539 A2 BRPI1013539 A2 BR PI1013539A2 BR PI1013539 A BRPI1013539 A BR PI1013539A BR PI1013539 A BRPI1013539 A BR PI1013539A BR PI1013539 A2 BRPI1013539 A2 BR PI1013539A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
neutral oil
sublingual pharmaceutical
sublingual
neutral
Prior art date
Application number
BRPI1013539A
Other languages
English (en)
Inventor
Clive Booles
Original Assignee
Londonpharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0906977A external-priority patent/GB2469792A/en
Priority claimed from PCT/GB2009/050416 external-priority patent/WO2010122276A1/en
Application filed by Londonpharma Ltd filed Critical Londonpharma Ltd
Publication of BRPI1013539A2 publication Critical patent/BRPI1013539A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI1013539A 2009-04-23 2010-04-23 composição farmacêutica sublingual compreendendo um óleo neutro BRPI1013539A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0906977A GB2469792A (en) 2009-04-23 2009-04-23 Oil-based pharmaceutical formulation for sublingual delivery
PCT/GB2009/050416 WO2010122276A1 (en) 2009-04-23 2009-04-23 Drug delivery
PCT/GB2010/050671 WO2010122355A1 (en) 2009-04-23 2010-04-23 Sublingual pharmaceutical composition comprising a neutral oil

Publications (1)

Publication Number Publication Date
BRPI1013539A2 true BRPI1013539A2 (pt) 2016-04-12

Family

ID=42236683

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1013539A BRPI1013539A2 (pt) 2009-04-23 2010-04-23 composição farmacêutica sublingual compreendendo um óleo neutro

Country Status (15)

Country Link
US (1) US20120058158A1 (pt)
EP (1) EP2421503A1 (pt)
JP (1) JP2012524771A (pt)
CN (1) CN102458358A (pt)
AU (1) AU2010240653A1 (pt)
BR (1) BRPI1013539A2 (pt)
CA (1) CA2756879A1 (pt)
IL (1) IL215454A (pt)
MX (1) MX2011010835A (pt)
MY (1) MY167918A (pt)
NZ (1) NZ595467A (pt)
RU (1) RU2011139638A (pt)
SG (1) SG175160A1 (pt)
WO (1) WO2010122355A1 (pt)
ZA (1) ZA201107089B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
CN101801415B (zh) 2007-05-25 2015-09-23 Rb医药品有限公司 利培酮化合物的持续递送制剂
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB2481017B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US20130254139A1 (en) * 2012-03-21 2013-09-26 Xiaoguang Lei Systems and methods for building a universal intelligent assistant with learning capabilities
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
US10376586B2 (en) 2016-02-16 2019-08-13 Entourage Bioscience, LLC Method and compositions for solubilizing non-polar constituents
BR112018072539A2 (pt) * 2016-05-05 2019-03-26 Aquestive Therapeutics, Inc. composições de epinefrina de administração aumentada
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
CN110325179A (zh) * 2016-12-26 2019-10-11 塞尔利克斯生物私人有限公司 用于治疗慢性疼痛的组合物和方法
WO2019067670A1 (en) * 2017-09-27 2019-04-04 Aquestive Therapeutics, Inc. EPINEPHRINE AND ENHANCED DELIVERY COMPOSITIONS
WO2021201680A1 (en) * 2020-03-31 2021-10-07 Hasan Djohan Treatment of hyperinflammatory syndrome

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2038696T3 (es) * 1986-03-10 1996-07-16 Burghart Kurt Procedimiento para producir un preparado farmaceutico.
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
WO2002064109A2 (en) * 2001-02-14 2002-08-22 Gw Pharma Limited Mucoadhesive pharmaceutical formulations
CA2637672C (en) * 2006-01-25 2012-07-24 Insys Therapeutics Inc. Sublingual fentanyl spray
JP2010535774A (ja) * 2007-08-06 2010-11-25 インシス セラピューティクス インコーポレイテッド 経口カンナビノイド液体製剤および治療方法
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition
ES2390046T3 (es) * 2009-04-23 2012-11-06 Londonpharma Ltd. Formulación de pulverización sublingual que comprende dihidroartemesinina

Also Published As

Publication number Publication date
CA2756879A1 (en) 2010-10-28
EP2421503A1 (en) 2012-02-29
NZ595467A (en) 2013-08-30
SG175160A1 (en) 2011-11-28
IL215454A0 (en) 2011-12-29
MY167918A (en) 2018-09-27
ZA201107089B (en) 2012-12-27
JP2012524771A (ja) 2012-10-18
RU2011139638A (ru) 2013-05-27
IL215454A (en) 2014-11-30
MX2011010835A (es) 2012-05-08
CN102458358A (zh) 2012-05-16
WO2010122355A1 (en) 2010-10-28
AU2010240653A1 (en) 2011-10-20
US20120058158A1 (en) 2012-03-08

Similar Documents

Publication Publication Date Title
BRPI1013539A2 (pt) composição farmacêutica sublingual compreendendo um óleo neutro
SMT201600307B (it) Composizione liposomiale
DK3078664T3 (da) Antiparasitiske dihydroazol-sammensætninger
FR2944289B1 (fr) Composition huileuse volatile
DOP2011000396A (es) Composiciones novedosas
DK3097925T3 (da) Farmaceutisk sammensætning
BR112012005242A2 (pt) composição de óleo anticorrosivo
BRPI1013588A2 (pt) composição
BRPI1004940A2 (pt) composição farmacêutica
DK2395834T3 (da) Natriumnitrit-holdige farmaceutiske sammensætninger
BR112012003977A2 (pt) composições que induzem ajuda de célula t
BRPI1012539A2 (pt) composições farmacêuticas
BRPI1006505A2 (pt) embalagem
BRPI1015474A2 (pt) composição
BRPI1015939A2 (pt) composição farmacêutica
BRPI1010690A2 (pt) composições
IT1394400B1 (it) Composizioni farmaceutiche
DK2339208T3 (da) Gear
BR112013015860A2 (pt) composição lubrificante contendo um detergente
BRPI1005318A2 (pt) composição
BR112012001340A2 (pt) composições farmacêuticas
BR112012003149A2 (pt) composição farmacêutica
BRPI0923528A2 (pt) engrenagem intermediária
BRPI1006076A2 (pt) composicoes farmaceuticas
DE112010002033B8 (de) Biohydrofuel-Zusammensetzungen

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL